Clover cancels AIM listing
Thursday, 19 January, 2006
Sydney-based Clover (ASX:CLV) has applied to the London Stock Exchange to cancel its listing on the Alternative Investment Market (AIM).
The cancellation is expected to take effect from February 16.
Clover's board felt that the costs associated with maintaining a dual listing on AIM and the ASX outweighed any benefits gained and the company will not be looking to raise new capital on AIM in the foreseeable future. All shareholdings registered in the UK on AIM will be automatically transferred following the delisting and will remain tradable as ordinary shares on the ASX.
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
